ask="N/A"
ask_size="N/A"
average_daily_volume="150684"
bid="14.54"
bid_size="200"
book_value="6.55"
change="+0.29"
change_from_200_day_moving_average="1.30"
change_from_50_day_moving_average="0.16"
change_from_52_week_high="-2.65"
change_From_52_week_low="4.83"
change_in_percent="+1.75%"
close="16.85"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.02"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="11787000"
high="16.91"
high_52_weeks="19.50"
last_trade_date="2/9/2017"
last_trade_price="16.85"
last_trade_size="2640"
last_trade_time="4:00pm"
low="16.53"
low_52_weeks="12.02"
market_capitalization="370.40M"
moving_average_200_day="15.55"
moving_average_50_day="16.69"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.67"
open="16.53"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+8.36%"
percent_change_from_50_day_moving_average="+0.93%"
percent_change_from_52_week_high="-13.59%"
percent_change_from_52_week_low="+40.18%"
previous_close="16.56"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.53"
price_per_sales="343.74"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="18.93"
stock_exchange="NGM"
symbol="ADMS"
volume="50599"
weeks_range_52="12.02 - 19.50"
